远程医疗平台Hims & Hers Health Inc.（股票代码：HIMS）今日盘前大涨5.14%，引起投资者广泛关注。这一显著涨幅主要源于公司宣布的一项重大收购计划。
据报道，Hims & Hers Health将收购总部位于伦敦的初创公司Zava，具体收购金额尚未披露。这项战略性收购将使Hims能够将其产品和服务扩展到德国、法国和爱尔兰等欧洲市场，显著增加其国际患者覆盖范围。Zava目前为英国、德国、法国和爱尔兰的100多万客户提供医疗咨询和处方药配送服务，包括热门减肥药Mounjaro和Wegovy。
此次收购对Hims & Hers Health的未来发展具有重要意义。公司计划在这些新市场为患者推出个性化的皮肤护理、减肥和其他产品，并将提供当地语言的医疗服务。这不仅有助于Hims扩大其国际业务规模，还能够增强公司的竞争力和长期增长潜力。值得注意的是，这项交易预计将于今年下半年完成，公司计划通过其资产负债表上的现金为收购提供资金。投资者对这一战略举措反应积极，推动了公司股价的大幅上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.